SCHEMBL20140941

SCHEMBL20140941

Cc1cc(C)c(C(=O)O)cc1CN1CCN(c2ccccc2C#N)C[C@@H]1C

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRM1 Q13255 2/20 0.46
DRD4 P21917 5/20 0.40
DRD2 P14416 3/20 0.40
DRD3 P35462 2/20 0.40
MTOR P42345 4/20 0.39
RPTOR Q8N122 4/20 0.39
MLST8 Q9BVC4 4/20 0.39
HTR2A P28223 3/20 0.39
KDM4E B2RXH2 2/20 0.39
ALDH1A1 P00352 2/20 0.39
CYP2D6 P10635 2/20 0.39
CYP1A2 P05177 1/20 0.39
CYP3A4 P08684 1/20 0.39
THPO P40225 1/20 0.39
HIF1A Q16665 1/20 0.39
CHRM4 P08173 1/20 0.37
GMNN O75496 1/20 0.37
LMNA P02545 1/20 0.37
THRB P10828 1/20 0.37
PMP22 Q01453 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20157463 0.87 GRM1 (0.41) GRM1DRD4DRD2DRD3MTOR
SCHEMBL20141467 0.84 ESR1 (0.41) ALDH1A1CHRM4LMNASLC6A9
SCHEMBL20140721 0.84 GRM1 (0.45) GRM1MTORRPTORMLST8CHRM4
SCHEMBL20157490 0.84 GRM1 (0.45) GRM1MTORRPTORMLST8CHRM4
SCHEMBL20140126 0.83 MTOR (0.53) DRD4DRD2DRD3MTORRPTOR
Hydrochloric Acid SCHEMBL20140671 0.83 MTOR (0.52) DRD4DRD2DRD3MTORRPTOR
SCHEMBL20140416 0.82 GRM1 (0.43) GRM1DRD4MTORRPTORMLST8
SCHEMBL20156987 0.82 GRM1 (0.43) GRM1DRD4DRD2DRD3MTOR
SCHEMBL20156953 0.81 GRM1 (0.41) GRM1DRD4DRD2DRD3MTOR
SCHEMBL20141016 0.80 MTOR (0.53) GRM1DRD4DRD2DRD3MTOR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018089433-A1 PHENYL mTORC INHIBITORS AND USES THEREOF NAVITOR PHARMACEUTICALS, INC. (US) 2018-05-17 WO disclosed